Boston Scientific Corporation (BSX)

NYSE: BSX · IEX Real-Time Price · USD

68.12

+0.68 (1.01%)

At close: Apr 16, 2024, 4:00 PM

68.75

+0.63 (0.92%)

After-hours: Apr 16, 2024, 4:24 PM EDT

Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	865	928	1,925	1,734	217	146	188	196	319	587	Upgrade
Cash & Cash Equivalents	865	928	1,925	1,734	217	146	188	196	319	587	Upgrade
Cash Growth	-6.79%	-51.79%	11.01%	699.08%	48.63%	-22.34%	-4.08%	-38.56%	-45.66%	170.51%	Upgrade
Receivables	2,228	1,970	1,778	1,531	1,828	1,608	1,548	1,472	1,275	1,183	Upgrade
Inventory	2,484	1,867	1,610	1,351	1,579	1,166	1,078	955	1,016	946	Upgrade
Other Current Assets	937	995	1,004	2,078	1,075	1,083	1,008	616	861	890	Upgrade
Total Current Assets	6,514	5,760	6,317	6,694	4,699	4,003	3,822	3,239	3,471	3,606	Upgrade
Property, Plant & Equipment	2,859	2,446	2,252	2,084	2,079	1,782	1,697	1,630	1,490	1,507	Upgrade
Goodwill and Intangibles	20,390	18,822	18,109	15,868	18,062	14,283	12,835	12,561	12,667	11,504	Upgrade
Other Long-Term Assets	5,373	5,441	5,551	6,131	5,725	931	688	666	505	407	Upgrade
Total Long-Term Assets	28,622	26,709	25,912	24,083	25,866	16,996	15,220	14,857	14,662	13,418	Upgrade
Total Assets	35,136	32,469	32,229	30,777	30,565	20,999	19,042	18,096	18,133	17,024	Upgrade
Accounts Payable	942	862	794	513	542	349	530	447	209	262	Upgrade
Current Debt	531	20	261	13	1,416	2,253	1,801	64	3	403	Upgrade
Other Current Liabilities	3,460	2,921	3,219	3,155	2,908	2,658	3,323	3,076	2,218	2,181	Upgrade
Total Current Liabilities	4,933	3,803	4,274	3,681	4,866	5,260	5,654	3,587	2,430	2,846	Upgrade
Long-Term Debt	8,571	8,915	8,804	9,130	8,592	4,803	3,815	5,420	5,674	3,841	Upgrade
Other Long-Term Liabilities	2,102	2,178	2,529	2,640	3,230	2,210	2,561	2,356	3,709	3,880	Upgrade
Total Long-Term Liabilities	10,673	11,093	11,333	11,770	11,822	7,013	6,376	7,776	9,383	7,721	Upgrade
Total Liabilities	15,606	14,896	15,607	15,451	16,688	12,273	12,030	11,363	11,813	10,567	Upgrade
Total Debt	9,102	8,935	9,065	9,143	10,008	7,056	5,616	5,484	5,677	4,244	Upgrade
Debt Growth	1.87%	-1.43%	-0.85%	-8.64%	41.84%	25.64%	2.41%	-3.40%	33.77%	0.09%	Upgrade
Retained Earnings	819	-750	-1,392	-2,378	-2,253	-6,953	-8,390	-8,581	-8,927	-8,689	Upgrade
Comprehensive Income	49	269	263	207	270	33	-59	1	88	144	Upgrade
Shareholders' Equity	19,282	17,573	16,622	15,326	13,877	8,726	7,012	6,733	6,320	6,457	Upgrade
Net Cash / Debt	-8,237	-8,007	-7,140	-7,409	-9,791	-6,910	-5,428	-5,288	-5,358	-3,657	Upgrade
Net Cash Per Share	-5.63	-5.56	-4.98	-5.23	-6.94	-4.93	-3.90	-3.84	-3.99	-2.76	Upgrade
Working Capital	1,581	1,957	2,043	3,013	-167	-1,257	-1,832	-348	1,041	760	Upgrade
Book Value Per Share	13.27	12.29	11.69	10.82	9.97	6.32	5.12	4.96	4.71	4.88	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).